GTBIF · Green Thumb Industries Inc. · Financials
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| $1.21B | $1.18B | $1.14B | $1.05B | $1.02B | $893.56M | $556.57M | $216.43M | $62.49M | |
| $642.49M | $600.4M | $536.03M | $528.06M | $513.41M | $401.63M | $252.4M | $109.4M | $34.18M | |
| $566.88M | $574.89M | $601.11M | $526.5M | $503.96M | $491.93M | $304.17M | $107.03M | $28.32M | |
| — | 48.91% | 52.86% | 49.93% | 49.54% | 55.05% | 54.65% | 49.45% | 45.31% | |
| $450.4M | $437.19M | $376.68M | $341.86M | $294.4M | $277.09M | $198.06M | $134.72M | $54.66M | |
| $48.21M | $49.91M | $50.39M | $50.84M | $59.66M | $45.21M | $37.03M | $24.47M | $2.5M | |
| $151.96M | $145.45M | $113.21M | $100.79M | $96.66M | $68.46M | $52.51M | $31.48M | $5.18M | |
| $450.4M | $437.19M | $376.68M | $341.86M | $382.9M | $277.09M | $198.06M | $134.72M | $54.66M | |
| $116.49M | $137.7M | $224.43M | $184.63M | $121.06M | $214.84M | $106.11M | -$27.69M | -$26.34M | |
| — | 11.72% | 19.74% | 17.51% | 11.9% | 24.04% | 19.06% | -12.79% | -42.15% | |
| $268.44M | $283.15M | $337.64M | $285.42M | $217.73M | $283.3M | $158.61M | $3.79M | -$21.16M | |
| $21.37M | $20.02M | $24.27M | $19.07M | $21.2M | $21.98M | $18.67M | $13.66M | $2.28M | |
| $163.93M | $125.66M | -$24.29M | -$28.58M | -$12.63M | -$9.87M | -$3.18M | -$22.51M | $56.09M | |
| -$1.88M | -$10.81M | -$8.69M | -$1.17M | -$4.26M | $1.8M | $2.32M | -$56K | — | |
| — | $29.88M | $0 | $0 | — | — | — | -$56.42K | -$55.75K | |
| $280.42M | $263.36M | $200.14M | $156.05M | $108.43M | $204.98M | $102.93M | -$50.2M | $29.75M | |
| $155.02M | $147.3M | $126.29M | $118.63M | $94.78M | $124.61M | $83.85M | $9.34M | $7.18M | |
| $126.77M | $114.15M | $73.08M | $36.27M | $11.98M | $75.44M | $14.99M | -$59.12M | -$5.24M | |
| — | 9.71% | 6.43% | 3.44% | 1.18% | 8.44% | 2.69% | -27.31% | -8.39% | |
| -$1.37M | $1.9M | $768K | $1.15M | $1.68M | $4.93M | $4.09M | -$430K | $27.81M | |
| USD/shares | $0.42 | $0.49 | $0.31 | $0.15 | $0.05 | $0.34 | $0.07 | -$0.31 | -$0.04 |
| USD/shares | $0.41 | $0.48 | $0.30 | $0.15 | $0.05 | $0.33 | $0.07 | -$0.31 | -$0.04 |
| shares | — | 233.87M | 236.83M | 237.93M | 236.71M | 223.19M | 210.99M | 190.6M | 130.1M |
| shares | — | 236.87M | 241.93M | 239.83M | 238.08M | 226.76M | 212.53M | 190.6M | 130.1M |
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 46 similar-size Drug Manufacturers - Specialty & Generic companies (of 100 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Retail Segment | $829,538,000 | $824,726,000 | $791,480,000 | $763,166,000 | $614,739,000 | $396,372,000 | $137,810,000 |
| Consumer Packaged Goods Segment | $677,350,000 | $648,388,000 | $559,480,000 | $495,101,000 | $36,839,000 | $273,977,000 | $109,930,000 |
| Intersegment Eliminations and Corporate | -$331,593,000 | -$335,973,000 | -$296,407,000 | -$240,892,000 | -$188,437,000 | -$113,776,000 | — |